Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.

por Tsai, J. F., Chang, W. Y., Jeng, J. E., Ho, M. S., Lin, Z. Y., Tsai, J. H.
Publicado 1994

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.

por Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Lin, Z. Y., Tsai, J. H.
Publicado 1995

Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.

por Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., Tsai, J. H.
Publicado 1996

Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.

por Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., Tsai, J. H.
Publicado 1997

Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study

por Tsai, J F, Chuang, L Y, Jeng, J E, Ho, M S, Hsieh, M Y, Lin, Z Y, Wang, L Y
Publicado 2001

Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.

por Tsai, J. F., Jeng, J. E., Chuang, L. Y., Yang, M. L., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., Tsai, J. H.
Publicado 1997

Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.

por Tsai, J. F., Jeng, J. E., Chuang, L. Y., Yang, M. L., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., Tsai, J. H.
Publicado 1997